Orbimed Advisors - COMPASS THERAPEUTICS INC ownership

COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 39 filers reported holding COMPASS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of COMPASS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$44,054,815
-38.1%
22,362,8500.0%0.94%
-27.4%
Q2 2023$71,113,863
-2.8%
22,362,8500.0%1.29%
-10.2%
Q1 2023$73,126,520
-35.0%
22,362,8500.0%1.44%
-33.3%
Q4 2022$112,485,136
+124.7%
22,362,850
+1.8%
2.15%
+131.6%
Q3 2022$50,071,000
-14.0%
21,960,8500.0%0.93%
-11.9%
Q2 2022$58,196,000
+96.3%
21,960,850
+1.5%
1.06%
+119.3%
Q1 2022$29,651,000
-56.8%
21,642,9750.0%0.48%
-45.5%
Q4 2021$68,608,00021,642,9750.88%
Other shareholders
COMPASS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 1,246,977$2,456,5453.92%
CHI Advisors LLC 2,829,712$5,574,5322.21%
Ally Bridge Group (NY) LLC 914,630$1,801,8212.12%
Monashee Investment Management LLC 1,226,142$2,415,5001.01%
Orbimed Advisors 22,362,850$44,054,8150.94%
Vivo Capital, LLC 3,556,023$7,005,3650.77%
CAXTON CORP 86,773$170,9420.65%
Prosight Management, LP 935,157$1,842,2590.58%
BRAIDWELL LP 5,954,273$11,729,9180.37%
Rock Springs Capital Management LP 5,513,788$10,862,1620.29%
View complete list of COMPASS THERAPEUTICS INC shareholders